If anyone believes that academic professors and other "experts" are always squeaky clean, neutral, haven't an agenda or can't be bought; then I guess you'll take humans being the main cause of climate change as kosher science.
In the U.S. while big pharma readies for battle with Trumpers - who called them out over exorbitant drug prices - the pharmaceutical industry is busy deploying economists and health care experts from the nation’s top universities.
Heaving under the weight of scholarly articles and blogs while booking conference venues, they lend their so called prestige to the lobbying blitz - while seldom disclosing their corporate sugar daddy.
The pharmaceutical industry is digging in. One of its trade groups to date has raised an additional $100 million for its “war chest.” For years, it has spent millions of dollars lobbying politicians, and being rather successful in enlisting their support on a wide range of legislation. It has similarly wooed doctors, seeking to influence what they research, teach and prescribe. Now, it’s courting health economists.
A thousand percent price rise for your life saving drug? Well, some "health economist" - before leaving you mud splattered from their wheel spinning Ferrari - has concluded you're still getting a real bargain.
Some may recall, the mantra "too big to fail"? Similar "experts" from the academic community - armed with empirical evidence - gave their backing to political elites; who in turn press ganged the ordinary, tax paying Chuck and Cindies of America, to join that 2008 Financial Crash Fiasco Party.
Beware the academic priesthood; a very large contingent of them couldn't get their Nazi Party membership card through the mail fast enough.
In the U.S. while big pharma readies for battle with Trumpers - who called them out over exorbitant drug prices - the pharmaceutical industry is busy deploying economists and health care experts from the nation’s top universities.
Heaving under the weight of scholarly articles and blogs while booking conference venues, they lend their so called prestige to the lobbying blitz - while seldom disclosing their corporate sugar daddy.
The pharmaceutical industry is digging in. One of its trade groups to date has raised an additional $100 million for its “war chest.” For years, it has spent millions of dollars lobbying politicians, and being rather successful in enlisting their support on a wide range of legislation. It has similarly wooed doctors, seeking to influence what they research, teach and prescribe. Now, it’s courting health economists.
A thousand percent price rise for your life saving drug? Well, some "health economist" - before leaving you mud splattered from their wheel spinning Ferrari - has concluded you're still getting a real bargain.
Some may recall, the mantra "too big to fail"? Similar "experts" from the academic community - armed with empirical evidence - gave their backing to political elites; who in turn press ganged the ordinary, tax paying Chuck and Cindies of America, to join that 2008 Financial Crash Fiasco Party.
Beware the academic priesthood; a very large contingent of them couldn't get their Nazi Party membership card through the mail fast enough.
